Walleye Capital’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24,600
Closed -$167K 4730
2025
Q4
$167K Sell
24,600
-6,605
-21% -$46.3K ﹤0.01% 3635
2025
Q3
$218K Buy
+31,205
New +$217K ﹤0.01% 3262
2023
Q4
Sell
-18,877
Closed -$138K 5285
2023
Q3
$138K Sell
18,877
-113,380
-86% -$845K ﹤0.01% 3777
2023
Q2
$874K Buy
+132,257
New +$674K ﹤0.01% 1964
2021
Q1
Sell
-11,473
Closed -$104K 1271
2020
Q4
$104K Buy
+11,473
New +$82.6K 0.01% 814

Other funds holding MDXG

Walleye Capital's MDXG Position: Q1 2026 in Review

Walleye Capital sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 24,600 shares — an estimated $167K sold.

Walleye Capital first reported a position in MDXG in Q4 2020 and held it in 5 quarters. The position peaked at $874K in Q2 2023. 238 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Walleye Capital reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
  • Walleye Capital sold 24,600 MiMedx Group shares in Q1 2026, an estimated $167K.
  • Walleye Capital first reported a position in MiMedx Group in Q4 2020 and held it in 5 quarters.
  • Walleye Capital's MiMedx Group position peaked at $874K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.